Am Investment Strategies »

Denali Therapeutics shares owned by Am Investment Strategies

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Am Investment Strategies from 13F filings

Historical chart of Am Investment Strategies investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Am Investment Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Am Investment Strategies

Quarter filed Position value Share count Share price at filing
2023-03-31 $346k 15k 23.02

More positions owned by Am Investment Strategies

Apple (AAPL)
Amazon (AMZN)
Berkshire Hathaway Inc Com Usd0.0033 Class B Cl B New (BRK.B)
Synovus Financial Corp Com Usd1.00 Com New (SNV)
Alphabet Inc Cap Stk Cl C Cap Stk Cl C (GOOG)
Meta Platforms Inc Class A Cl A (META)
General Electric Com New (GE)
Raymond James Financial (RJF)
Goldman Sachs (GS)
Microsoft Corporation (MSFT)
Adtalem Global Ed (ATGE)
Seacoast Banking Corporation Of Florida Com New (SBCF)
Us Bancorp Com New (USB)
Apollo Global Mgmt (APO)
Southern Company (SO)

View all positions for Am Investment Strategies

Top funds holding Denali Therapeutics

Baillie Gifford & Co
Vanguard Group
Wellington Management Company
Crestline Management
Baker Bros. Advisors
T. Rowe Price Associates
Flagship Ventures Management
Bank of New York Mellon
Marshall Wace
Credit Suisse
Federated Investors
Casdin Capital
Gilder, Gagnon, Howe & Co
Norges Bank Investment Management
Yiheng Capital

View all funds holding Denali Therapeutics